It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objective: Paracetamol is an analgesic and antipyretic agent that widely used throughout the world. The increase of the usage and its easy accessibility brings along the toxicity risk. Paracetamol toxicity may result in drug induced hepatotoxicity and nephrotoxicity. Anti-inflammatory and antioxidant effects of amlodipine which creates vasodilatation by blocking L-type calcium channels and its usage in elderly for renoprotective purposes, ponders that it might be favorable in cases with inflammation such renal damage inducted with paracetamol. Thus, aim of our study is to analyze effects of amlodipine, one of L-type calcium channel blockers, in acute renal damage inducted with paracetamol. Methods: 30 male rats consisting of 5 groups were used in our study. Groups; I: Health Control group. 2 ml Phosphate-buffered saline (PBS) oral was administered. II: 10 mg/kg Amlodipine III: Paracetamol (2g/kg) IV: 5 mg/kg Amlodipine + paracetamol V: 10 mg/kg Amlodipine + paracetamol. Rats were sacrificed after 24 hours following paracetamol administration. Results: Serum levels of creatinine and blood urea nitrogen (BUN) were increased in paracetamol group, those parameters improved in amlodipine groups. While superoxide dismutase (SOD) activity and glutathione (GSH) levels measured in kidney decreased in paracetamol group, amlodipine has significantly corrected these parameters. Meanwhile malondialdehyde (MDA) quantities increased in paracetamol group, it has been seen that in the amlodipine administered groups quantities of increased MDA have statistically significantly decreased Conclusion: This study showed that amlodipine has protective effects against paracetamol toxicity in kidney. Amlodipine revealed its protective effects by suppressing the oxidative damage and improving antioxidant activity. Amlodipine can be drug of choice in hypertensive patients with analgesic nephropathies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





